$2.64
-0.06-2.22%
At close: Jun 12, 5:00 PM EST
$2.69
0.05482.08%
After Hours: Jun 12, 4:44 PM EST
Moleculin Biotech Inc Earnings Estimates
MBRXNASDAQ
Moleculin Biotech Earnings Estimates, EPS & Revenue | NASDAQ:MBRX
Moleculin Biotech (MBRX) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-1.63 and quarterly revenue of N/A.
In the most recent quarter (Q1), Moleculin Biotech reported EPS of $-3.54, missing estimates of $-1.67 by 1.12%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Moleculin Biotech has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Moleculin Biotech has averaged an EPS surprise of 2.03% and a revenue surprise of 0.00%.
Earnings Date
Aug 11
EPS Estimate
$-1.630
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Moleculin Biotech Earnings History
Analyze the earnings history of Moleculin Biotech using advanced sorting and filters.
Loading calendar...
Moleculin Biotech (MBRX) Earnings Per Share
The chart below shows Moleculin Biotech's reported EPS compared to analyst estimates over recent quarters.
Moleculin Biotech (MBRX) Revenue
The chart below shows Moleculin Biotech's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?
Moleculin Biotech (MBRX) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for Moleculin Biotech (NASDAQ:MBRX)?
The Actual EPS was $-3.54, which missed the estimate of $-1.67.
What were Moleculin Biotech’s (NASDAQ:MBRX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
